Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 5, Mai 2009
Évaluation des risques et perspectives thérapeutiques en oncologie colorectale
Page(s) 467 - 472
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009255467
Publié en ligne 15 mai 2009
  1. Cullen BR. Transcription and processing of human microRNA precursors. Mol cell 2004; 16 : 861–5. [Google Scholar]
  2. Finoux AL, Chartrand P. Oncogenic and tumour suppressor microRNAs. Med Sci (Paris) 2008; 24 : 1049–54. [Google Scholar]
  3. Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Sem in Oncol 2006; 33 : 167–73. [Google Scholar]
  4. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102 : 13944–9. [Google Scholar]
  5. Linsley PS, Schelter J, Burchard J, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27 : 2240–52. [Google Scholar]
  6. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435 : 834–8. [Google Scholar]
  7. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs : key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27 : 5959–74. [Google Scholar]
  8. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101 : 9740–4. [Google Scholar]
  9. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies : molecular, clinical and therapeutic implications. Leukemia 2008; 22 : 1095–105. [Google Scholar]
  10. Ma L, Weinberg RA. Micromanagers of malignancy : role of microRNAs in regulating metastasis. Trends Genet 2008; 24 : 448–56. [Google Scholar]
  11. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Meth 2004; 1 : 155–61. [Google Scholar]
  12. Rebouissou S, Couchy G, Libbrecht L, et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008; 49 : 61–71. [Google Scholar]
  13. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32 : 312–5. [Google Scholar]
  14. Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms : beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002; 36 : 927–35. [Google Scholar]
  15. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma : new classification and relationship with HCC. Hepatology 2006; 43 : 515–24. [Google Scholar]
  16. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2008; 457 : 200–4. [Google Scholar]
  17. Zucman-Rossi J, Amessou M, Bioulac-Sage P, Rebouissou S. Gp130 activating mutations in inflammatory adenomas. Med Sci (Paris) 2008; 24 : 1113–4. [Google Scholar]
  18. Boyault S, Rickman DS, de Reynies A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45 : 42–52. [Google Scholar]
  19. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology (Baltimore, Md 2008; 47 : 1955–63. [Google Scholar]
  20. Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14 : 419–27. [Google Scholar]
  21. Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47 : 1223–32. [Google Scholar]
  22. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25 : 2537–45. [Google Scholar]
  23. Kutay H, Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99 : 671–8. [Google Scholar]
  24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133 : 647–58. [Google Scholar]
  25. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67 : 6092–9. [Google Scholar]
  26. Huang YS, Dai Y, Yu XF, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23 : 87–94. [Google Scholar]
  27. Wang Y, Lee AT, Ma JZ, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008; 283 : 13205–15. [Google Scholar]
  28. Connolly E, Melegari M, Landgraf P, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008; 173 : 856–64. [Google Scholar]
  29. Varnholt H. The role of microRNAs in primary liver cancer. Ann Hepatol 2008; 7 : 104–13. [Google Scholar]
  30. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008; 48 : 648–56. [Google Scholar]
  31. Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harbor symposia on quantitative biology 2006; 71 : 369–76. [Google Scholar]
  32. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283 : 1026–33. [Google Scholar]
  33. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282 : 23716–24. [Google Scholar]
  34. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009; 136 : 683–93 [Google Scholar]
  35. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008; 47 : 897–907. [Google Scholar]
  36. Bousquet M, Dastugue N, Brousset P. MicroARN et translocations chromosomiques dans les hémopathies malignes. Med Sci 2009 (sous presse). [Google Scholar]
  37. Dunoyer P. La bataille du silence : mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009; 25 : 505–11. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.